Neurological Disorders Now Top Global Cause of Disability

The Hidden Epidemic: Why Neurological Disorders Are Now the World's Leading Cause of Disability

In 2016, a quiet catastrophe became impossible to ignore. For the first time in human history, the collective burden of neurological disorders—stroke, migraine, dementia, meningitis, epilepsy, and a dozen other conditions—outstripped every other category of disease when measured by years of healthy life lost. The numbers are staggering: 276 million disability adjusted life years (DALYs) lost to these disorders globally in a single year, according to Feigin et al. (2019) in The Lancet Neurology. That is roughly the equivalent of every person in the United States losing a full year of healthy life simultaneously.

The study, part of the Global Burden of Disease (GBD) 2016 analysis, tracked 15 neurological disorder categories across 195 countries from 1990 to 2016. It used two complementary methods: DisMod MR 2.1, a Bayesian meta regression tool for estimating prevalence and incidence, and the Cause of Death Ensemble model (CODEm) for mortality. The researchers analyzed 84 risk factors and their combinations. What they found changes how we should think about health policy, aging, and what it means to be disabled.

The Numbers That Broke the Record

The absolute numbers are climbing. Deaths from neurological disorders rose 39 percent between 1990 and 2016, while DALYs increased 15 percent (Feigin et al., 2019). But here is the paradox: age standardized rates actually dropped by 27 percent for DALYs and 28 percent for deaths. The difference is population growth and aging. More people are alive, more are old, and neurological disorders are diseases of age. The authors found that the only categories showing declines in both absolute and age adjusted numbers were tetanus, meningitis, and encephalitis—infectious conditions that modern medicine has learned to prevent and treat.

This means we are winning the battle against infectious neurological killers while losing ground to degenerative and chronic conditions. Stroke alone accounted for 42.2 percent of all neurological DALYs. Migraine contributed 16.3 percent. Alzheimer's and other dementias added 10.4 percent. Meningitis, once a leading cause, fell to 7.9 percent (Feigin et al., 2019).

Who Gets Hit Hardest?

The burden is not evenly distributed. Feigin and colleagues found that men carried a higher age standardized DALY rate for neurological disorders overall, with a male to female ratio of 1.12. But that aggregate number hides a striking pattern. Migraine, multiple sclerosis, and tension type headache were more common and caused more disability in women, with male to female ratios below 0.7. Migraine alone accounts for more than 16 percent of the neurological burden globally. It is not a headache. It is a disabling condition that millions of women navigate without adequate treatment.

The geographic distribution is equally uneven. Countries with lower incomes bear disproportionate burden from infectious neurological causes like meningitis and tetanus. Richer countries see more stroke and dementia. But the trend lines converge. As populations age everywhere, the chronic neurological disorders will dominate everywhere.

The Mystery of What Causes Most of This

Here is where the study becomes genuinely unsettling. Feigin et al. (2019) quantified 84 different risk factors—smoking, diet, air pollution, physical inactivity, hypertension, and dozens more—to see how much of the neurological burden they could explain. For stroke, the answer was clear: 88.8 percent of DALYs were attributable to known, modifiable risks. That is good news. It means stroke is largely preventable.

For Alzheimer's and other dementias, the number dropped to 22.3 percent. For idiopathic epilepsy, 14.1 percent. For the rest of the neurological disorders combined, less than 10 percent of the burden could be explained by any of the 84 risk factors measured (Feigin et al., 2019). This is not a failure of the study. It is a gap in knowledge. We do not know why migraine happens. We do not know what causes most cases of dementia. We do not know why multiple sclerosis appears. The risk factors we can measure barely scratch the surface.

This finding has uncomfortable implications. If you want to prevent stroke, you can tell people to stop smoking, control their blood pressure, eat better, and exercise. Those interventions work. But if you want to prevent migraine or dementia or Parkinson's, you cannot give similar advice because the science does not support it yet. The authors are explicit: "The scarcity of established modifiable risks for most of the neurological burden demonstrates that new knowledge is required" (Feigin et al., 2019).

What This Means for Health Systems

The numbers project a future that most governments are not prepared for. As populations age and grow, the absolute burden of neurological disorders will increase. The study found that prevalence of major disabling neurological disorders rises steeply with age. Dementia, Parkinson's, stroke—these are not rare diseases of old age. They are common, and they are becoming more common.

Health systems built around acute care and infectious disease management are poorly equipped for chronic neurological disability. A stroke survivor may need years of rehabilitation. A person with dementia requires daily support for a decade or more. Someone with chronic migraine may cycle through a dozen treatments before finding one that works. The authors note that governments will face "increasing demand for treatment, rehabilitation, and support services" (Feigin et al., 2019). That is diplomatic language for a looming crisis.

The Gender Paradox

The study reveals a hidden asymmetry. Men have higher rates of death and disability from neurological disorders overall, driven largely by stroke. But women bear a heavier burden from conditions that are less fatal but more disabling over a lifetime. Migraine peaks in the reproductive years. Multiple sclerosis often strikes young adults. Dementia disproportionately affects women, partly because they live longer.

This means that the same disorder can look completely different depending on who gets it. A man in his 60s with stroke may die quickly or recover partially. A woman in her 30s with migraine may lose decades of productive life to a condition that is underdiagnosed and undertreated. The DALY metric captures this, but policy often does not.

What the Study Does Not Prove

This is not a claim that neurological disorders are now the single biggest problem in global health. Cardiovascular disease and cancer still kill more people. The study measures disability, not just death. And disability adjusted life years combine both. Neurological disorders lead in DALYs because they are both common and disabling, not because they are the most lethal.

The study also does not prove causation for any of the risk factors it examines. The GBD comparative risk assessment approach estimates attributable burden based on existing epidemiological evidence. That evidence is strong for stroke, weaker for dementia, and nearly absent for migraine. Correlation is not causation, and the 84 risk factors may not include the ones that matter most.

Finally, the study does not tell us what to do about the 90 percent of neurological burden that cannot be explained by known risks. It tells us we need more research. That is honest but unsatisfying.

What This Actually Means

• ▸The global health community needs to shift focus from preventing death to preventing disability. Neurological disorders are the leading cause of healthy life lost, and that burden will grow as populations age. Funding and policy should reflect this reality, not the mortality statistics of the past century.

• ▸Stroke prevention works and should be a priority everywhere. The study found that nearly 90 percent of stroke burden is attributable to modifiable risks. Blood pressure control, smoking cessation, and diet changes are proven interventions. We know what to do. The gap is implementation.

• ▸Research funding for non stroke neurological disorders is dangerously low. If less than 10 percent of the burden from migraine, dementia, multiple sclerosis, and epilepsy can be explained by known risks, then basic science into their causes is not a luxury. It is a necessity. The current funding levels are not commensurate with the disability they cause.

• ▸Health systems must plan for long term neurological disability, not just acute episodes. Stroke rehabilitation, dementia care, and chronic pain management require different infrastructure than emergency rooms and ICUs. Countries that ignore this will be overwhelmed in the next two decades.

• ▸The gender gap in neurological disability is a policy blind spot. Women bear a disproportionate burden from migraine, multiple sclerosis, and dementia. Diagnostic delays, treatment disparities, and research neglect perpetuate this. Addressing it requires explicit attention, not just general health system improvement.

The world has a new leading cause of disability. It is not a virus. It is not an accident. It is the slow, cumulative toll of brains that break down as bodies age, of migraines that steal decades, of dementias that erase lives. The study from Feigin and colleagues is a map of a territory we have not fully explored. But the map is clear enough to show one thing: we are not prepared.